PRDX1 knockdown promotes erastin-induced ferroptosis and impedes diffuse large B-cell lymphoma development by inhibiting the MAPK/ERK pathway. (PubMed, BMC Cancer) - May 1, 2025 - "PRDX1 knockdown facilitates erastin-induced ferroptosis and obstacles DLBCL progression by inhibiting the MAPK/ERK pathway, offering a potential treatment strategy for DLBCL treatment."
Journal • B Cell Lymphoma • Diffuse Large B Cell Lymphoma • Hematological Malignancies • Lymphoma • Non-Hodgkin's Lymphoma • Oncology • GPX4 • MT-CO2 • PRDX1 • SLC7A11
|
|
Chuanming Lin; Jianzhen Shen; Menger Wang; Shuiling Xie
|